Clinuvel PharmaceuticalsCUV 
$9.82-0.67%24h
-0.67%24h
Global rank11480
Market cap$485.22M
Change 7d-5.64%
YTD Performance-8.06%
SP500 benchmarkUnderperform
P/E16.62
P/S9.29
Revenue$52.25M
Earnings$20.42M
Dividend yield-
Main Sector
Healthcare
Category
Clinuvel Pharmaceuticals CUV Total Debt
CUV Total Debt in 2022: $466.34K
According to Clinuvel Pharmaceuticals latest financial reports the total debt is $466.34K, an decrease of -25.75% to 2022. At the end of 2022 company had $628.08K total debt. This figure represents the debts and financial obligations that Clinuvel Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Clinuvel Pharmaceuticals CUV Total Debt History from 2023 to 2022
-
Value:-
CUV Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $466.34K | -25.75% |
| 2022 | $628.08K | -9.93% |
| 2021 | $697.31K | -5.60% |
| 2020 | $738.67K | 546.49% |
| 2019 | $114.26K | - |
View the Top Total Debt Stocks 
